ACT Genomics
ACT Genomics is a cancer solution provider. They offer precision medicine services in Taiwan, Singapore, Hong Kong, and Japan. They combine experts of tumor biology, cancer genomics, and bioinformatics to provide treatment guidelines for solid tumors, relapse, drug resistance, as well as cancer monitoring, risk assessment, and immunotherapy evaluation.
Last updated on
About ACT Genomics
Founded
2014Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$21MCategory
Industry
Engineering, Accounting, Research, Management, and Related ServicesLocation
City
TaipeiState
TaipeiCountry
TaiwanACT Genomics
Find your buyer within ACT Genomics